Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 1/2 5Phase 1 5Phase NA 2Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 2Orbital lymphoma 1Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 25Rituximab 18fludarabine phosphate 15Radiotherapy 13Methotrexate 13Peripheral Blood Stem Cell Transplantation 12Filgrastim 12Cytarabine 12Vincristine 11Melphalan 10Cyclosporine 10Busulfan 10Antilymphocyte Serum 10Exercise 9Doxorubicin 9Prednisone 7Mycophenolic Acid 7Magnetic Resonance Spectroscopy 7Etoposide 7Early Intervention, Educational 7Whole-Body Irradiation 6Surveys and Questionnaires 6Prednisolone 6Palliative Care 6Methods 6Leucovorin 6Educational Status 6Blood Specimen Collection 6Dexamethasone 5pegylated granulocyte colony-stimulating factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma × ibritumomab tiuxetan × Clear all
NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled 3 charts
Lymphoid

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT00082836 2013-01-17

Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
10 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡